Jo Min Seop, Jeong Jin Yong
*Department of Thoracic and Cardiovascular Surgery, St Vincent's Hospital, College of Medicine, The Catholic University of Korea †Department of Thoracic and Cardiovascular Surgery, Incheon St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
J Craniofac Surg. 2017 Oct;28(7):e706-e707. doi: 10.1097/SCS.0000000000003904.
I read with great interest the article reported by Efe et al in Journal of Cranofacial Surgery (2016;27:1802-1803), presenting the excellent result obtained by the use of sclerotherapy with single-dose OK-432 in a growing cervical lymphangioma. Cervicothoracic lymphangioma is a rare congenital anomaly that is mostly asymptomatic. We would like to share our experience of a rare cause of dyspnea by lymphangioma. In our case, the patient presented with dyspnea and paroxysmal cough caused by cervicothoracic lymphangioma and sclerotherapy alleviated tracheal compression and relieved the dyspneic symptoms.
我饶有兴趣地阅读了埃菲等人发表在《颅面外科杂志》（2016年；27卷：1802 - 1803页）上的文章，该文章介绍了使用单剂量溶链菌制剂进行硬化治疗在生长性颈部淋巴管瘤中取得的优异效果。颈胸段淋巴管瘤是一种罕见的先天性异常，大多无症状。我们想分享我们关于淋巴管瘤导致呼吸困难这一罕见原因的经验。在我们的病例中，患者因颈胸段淋巴管瘤出现呼吸困难和阵发性咳嗽，硬化治疗减轻了气管压迫并缓解了呼吸困难症状。
